The paper presents the synthesis of newly prepared derivatives of 6-methyl-2-phenyl-4-phenylamino-5-aminomethylpyrimidine and 5-methyl-1,7-diphenyl-l,2,3,4-tetrahydropyrimido[4,5-d]pyrimidine and also the results of microbiological studies. Pyrimidopyrimidine derivatives prepared show a certain analogy in their chemical structure to quinolone structures and also-as it might have been expected -they inhibit to a large extent the growth of bacterial strains, in some cases better than some antibiotics and sulfonamides used at present.
Introduction
Our earlier works on synthesis and biological properties of the pyrimidine ring indicated that this system is extremely biologically active. The derivatives synthesized showed cytostatic [ I , 21, imrnunomodulative [3, 41 and, above all, antibacterial properties [ 5 , 6, 7, 81 . Therefore, it was advisable to conduct a number of syntheses to obtain pyrimidopyrimidine derivatives and to subject them to microbiological examinations. 
CHEMISTRY
In our studies 2-phenyl-6-methyl-4-thio-5-pyrimidinecarboxylic acid ( 1 ) was used as a parent substance. It was melted with various amines yielding
4-arylamino-6-methyl-2-phenyl-5-pyrimidinecarboxylic acid (2) [5].
Pyrimidine acids 2 obtained were reduced with LiAlH4 [3] . 4-Arylamino-6-methyl-2-phenyl-5-hydroxymethylpyrimidines (3) prepared in this way were then transformed into 2-arylamino-6-methyl-2-phenyl-5-chloromethylpyrimidines (4) by means of SOC12. Then pyrimidine chloroderivatives 4 were treated with 25% aqueous ammonia solution yielding 4-arylamino-6-methyl-2-phenyl-5-aminomethylpyrimidines (5) [8]. Pyrimidine Saminoderivatives 5 were cyclized by means of 40% aqueous formaldehyde solution to pyrimidopyrimidines 6. Newly formed pyrimidine derivatives 5 and 6 were subject to microbiological examinations by checking their antibacterial and antifungal activity on standard strains (table 1, 2) . 
RESULTS AND DISCUSSION
Microbiological activity of compounds obtained was evaluated on selected bacterial strains. Determinations were carried out by the cylinder method, defining the growth inhibition zones on agar plates, incubated for 24 hours in an incubator (at 36°C). After that a reading was taken. Assessment of the activities of substances under investigation was carried out according to Pharrnacopea Polonica V [9]. Absolute activity was determined by defining the lowest concentration capable of inhibiting the growth of bacterial strains (MIC) in liquid medium and expressed in micrograms (pg) of the substance under investigation per 1 ml. Relative activity was determined as MIC value of the investigated substance by MIC value of pattern (Sulfacarbamide, Erythromycin). The results obtained are presented in The compounds prepared showed an extremely interesting antibacterial activity as compared with the standard sulfonamide used in medical care -Sulfacarbamide and some of them were even stronger bacterial growth inhibitors than presently used antibiotics -Erythromycin. Antihngal tests have also been found satisfactory. It appears that cyclization of pyrimidine 5-amino derivatives increases significantly antibacterial activity in many cases. These pyrimidopyrimidine derivatives exhibit particularly significant antibacterial effects if the phenyl ring contains a highly electronegative substitute, for instance, a chlorine atom. It should also be noted that these compounds show also antihngal action strongly inhibiting the growth of Candida albicans which may be a good omen for our future research work. Bromophenylamino)-6-methyl-2-phenyl-5-pyrimidine carboxylic acid  (2) 4g (1 6.3 rnrnol.) of 6-methyl-4-thio-5-pyrimidine carboxylic acid (1) was hsed with 3 g of o-bromoaniline for 5 hours. After hydrogen sulfide ceased to evolve, the reaction mixture was transferred into 50 ml of methanol and cooled down. The raw precipitate was filtered off and recrystallized from methanol yielding 5.7 g (9 1.3%) of yellow crystals of m.p. 4g (10.8 rnrnol.) of 4-(2'-bromopheny1amino)-6-methyl-2-phenyl-5-hydroxymethylpyrimidine (3) was dissolved in 50 ml benzene and 3 ml SOC12 was added. The mixture was put away for two hours at room temperature. Then the excess of thionyl chloride was evaporated from the reaction mixture and the raw residue was crystallized from chloroform yielding 3. Compounds 5b-5g were prepared in a similar way. Bromopheny1)-5-methyl-7-phenyl-1, 2, 3, 4-tetrahydro-pyrimido[4,5-dj  pyrimidine (6a) 4 g (10.8 mmol.) of 4-(2'-Bromopheny1amino)-6-methyl-2-phenyl-5-aminomethylpyrimidine (5a) was dissolved in 50 ml of THF and treated with 20 ml 40 %aqueous formaldehyde solution and 1 ml of concentrated HCl. The mixture was heated under reflux for 7 hours. Then the reaction mixture was cooled down and poured into 100 ml H20. The aqueous solution was extracted three times with chloroform. Chloroform extracts were combined and dried over MgS04. The oily mixture was purified with chloroform in a chromatographic column, collecting the Rf 8/10 fraction. 
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